Search Results - "Stinson, Sherman F."

Refine Results
  1. 1
  2. 2
  3. 3

    17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models by Burger, Angelika M, Fiebig, Heinz-Herbert, Stinson, Sherman F, Sausville, Edward A

    Published in Anti-cancer drugs (01-04-2004)
    “…17-(Allylamino)-17-demethoxygeldanamycin (17-AAG) is a semisynthetic antitumor agent, which has entered phase I/II clinical trials. Melanoma cell lines in the…”
    Get full text
    Journal Article
  4. 4

    Optimization of Naphthalimide-imidazoacridone with Potent Antitumor Activity Leading to Clinical Candidate (HKH40A, RTA 502) by Hariprakasha, Humcha K, Kosakowska-Cholody, Teresa, Meyer, Colin, Cholody, Wieslaw M, Stinson, Sherman F, Tarasova, Nadya I, Michejda, Christopher. J

    Published in Journal of medicinal chemistry (15-11-2007)
    “…Unsymmetrical bifunctional antitumor agent WMC79 was further optimized to generate compound 7b that not only inhibited the growth of many tumor cell lines, but…”
    Get full text
    Journal Article
  5. 5

    Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells by BRANTLEY, Eileen, ANTONY, Smitha, KOHLHAGEN, Glenda, LINGHUA MENG, AGAMA, Keli, STINSON, Sherman F, SAUSVILLE, Edward A, POMMIER, Yves

    Published in Cancer chemotherapy and pharmacology (01-07-2006)
    “…The fluorinated benzothiazole analogue 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) exhibits selective and potent anticancer activity,…”
    Get full text
    Journal Article
  6. 6

    Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles by Bradshaw, Tracey D, Bibby, Michael C, Double, John A, Fichtner, Iduna, Cooper, Patricia A, Alley, Michael C, Donohue, Susan, Stinson, Sherman F, Tomaszewjski, Joseph E, Sausville, Edward A, Stevens, Malcolm F G

    Published in Molecular cancer therapeutics (01-02-2002)
    “…Novel 2-(4-aminophenyl)benzothiazoles (e.g., compounds 1 and 2) possess highly selective, potent antitumor properties in vitro and in vivo. Elucidation of the…”
    Get full text
    Journal Article
  7. 7

    The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-κB activity in drug-sensitive MCF-7 cells by Brantley, Eileen, Patel, Vyomesh, Stinson, Sherman F, Trapani, Valentina, Hose, Curtis D, Ciolino, Henry P, Yeh, Grace C, Gutkind, J Silvio, Sausville, Edward A, Loaiza-Pérez, Andrea I

    Published in Anti-cancer drugs (01-02-2005)
    “…2-(4-Amino-3-methylphenyl)-5-fluoro-benzothiazole (5F 203) potently inhibits MCF-7 breast cancer cell growth in part by activating the aryl hydrocarbon…”
    Get full text
    Journal Article
  8. 8

    Synthesis, structure-activity relationship, and p210(bcr-abl) protein tyrosine kinase activity of novel AG 957 analogs by Kaur, Gurmeet, Narayanan, Ven L, Risbood, Prabhakar A, Hollingshead, Melinda G, Stinson, Sherman F, Varma, Ravi K, Sausville, Edward A

    Published in Bioorganic & medicinal chemistry (01-03-2005)
    “…A series of novel, sterically hindered lipophilic analogs of AG 957 was designed and synthesized as potential protein tyrosine kinase (PTK) inhibitors. The in…”
    Get full text
    Journal Article
  9. 9

    Clinical Pharmacology of Flavopiridol Following a 72-Hour Continuous Infusion by Rudek, Michelle A, Bauer, Kenneth S, Jr, Lush, Richard M, III, Stinson, Sherman F, Senderowicz, Adrian M, Headlee, Donna J, Arbuck, Susan G, Cox, Michael C, Murgo, Anthony J, Sausville, Edward A, Figg, William D

    Published in The Annals of pharmacotherapy (01-10-2003)
    “…Background Flavopiridol, a novel flavone derivative, inhibits cyclin-dependent kinase-1. We initiated a Phase I trial in patients with refractory solid tumors…”
    Get full text
    Journal Article
  10. 10

    Poly(ethylene glycol) Prodrugs of the CDK Inhibitor, Alsterpaullone (NSC 705701):  Synthesis and Pharmacokinetic Studies by Greenwald, Richard B, Zhao, Hong, Xia, Jing, Wu, Dechun, Nervi, Stephen, Stinson, Sherman F, Majerova, Eva, Bramhall, Chris, Zaharevitz, Daniel W

    Published in Bioconjugate chemistry (01-09-2004)
    “…Two methods were devised to conjugate PEG to alsterpaullone (NSC 705701) via the N of the indole ring portion of the molecule. In the first approach,…”
    Get full text
    Journal Article
  11. 11

    Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding protein by Schnier, Joachim B., Kaur, Gurmet, Kaiser, Astrid, Stinson, Sherman F., Sausville, Edward A., Gardner, John, Nishi, Kayoko, Bradbury, E.Morton, Senderowicz, Adrian M.

    Published in FEBS letters (02-07-1999)
    “…The synthetic flavone flavopiridol can be cytostatic or cytotoxic to mammalian cells, depending on the concentration of the drug and the duration of exposure…”
    Get full text
    Journal Article
  12. 12

    Selective toxicity of the tricyclic thiophene NSC 652287 in renal carcinoma cell lines: Differential accumulation and metabolism by Rivera, Maria I, Stinson, Sherman F, Vistica, David T, Jorden, Jean L, Kenney, Susan, Sausville, Edward A

    Published in Biochemical pharmacology (01-06-1999)
    “…The tricyclic compound 2,5-bis(5-hydroxymethyl-2-thienyl)furan (NSC 652287) has shown a highly selective pattern of differential cytotoxic activity in the…”
    Get full text
    Journal Article
  13. 13

    Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening by LIN WU, SMYTHE, A. M, SHOEMAKER, R. H, STINSON, S. F, MULLENDORE, L. A, MONKS, A, SCUDIERO, D. A, PAULL, K. D, KOUTSOUKOS, A. D, RUBINSTEIN, L. V, BOYD, M. R

    Published in Cancer research (Chicago, Ill.) (01-06-1992)
    “…Disease-oriented panels of human tumor cell lines used by the National Cancer Institute for large-scale in vitro anticancer drug screening were evaluated for…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms by Senderowicz, A M, Headlee, D, Stinson, S F, Lush, R M, Kalil, N, Villalba, L, Hill, K, Steinberg, S M, Figg, W D, Tompkins, A, Arbuck, S G, Sausville, E A

    Published in Journal of clinical oncology (01-09-1998)
    “…We conducted a phase I trial of the cyclin-dependent kinase inhibitor, flavopiridol (National Service Center [NSC] 649890), to determine the maximum-tolerated…”
    Get more information
    Journal Article
  17. 17

    Multifactorial hamster respiratory carcinogenesis with interdependent effects of cannula-induced mucosal wounding, saline, ferric oxide, benzo[a]pyrene and N-methyl-N-nitrosourea by KEENAN, K. P, SAFFIOTTI, U, STINSON, S. F, RIGGS, C. W, MCDOWELL, E. M

    Published in Cancer research (Chicago, Ill.) (15-03-1989)
    “…The carcinogenic response induced in the respiratory tract of Syrian golden hamsters by repeated intratracheal instillations of benzo[a]pyrene (BP) adsorbed to…”
    Get full text
    Journal Article
  18. 18

    Morphological and cytokinetic responses of hamster airways to intralaryngeal or intratracheal cannulation with instillation of saline or ferric oxide particles in saline by KEENAN, K. P, SAFFIOTTI, U, STINSON, S. F, RIGGS, C. W, MCDOWELL, E. M

    Published in Cancer research (Chicago, Ill.) (15-03-1989)
    “…The morphological and proliferative effects of intratracheal cannulation (ITC) or intralaryngeal cannulation (ILC), with or without the instillation of saline…”
    Get full text
    Journal Article
  19. 19

    Role of CYP1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells by CHUA, Mei-Sze, KASHIYAMA, Eiji, BRADSHAW, Tracey D, STINSON, Sherman F, BRANTLEY, Eileen, SAUSVILLE, Edward A, STEVENS, Malcolm F. G

    Published in Cancer research (Chicago, Ill.) (15-09-2000)
    “…2-(4-Amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) is a candidate antitumor agent with potent and selective activity against human-derived tumor cell…”
    Get full text
    Journal Article
  20. 20